For the quarter ending 2025-09-30, ONMD made $177K in revenue. -$741K in net income. Net profit margin of -418.64%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenue | 177 | 155 | 137 | 142 |
| Cost of revenue | 399 | 396 | 361 | 226 |
| Gross margin | -222 | -241 | -224 | -84 |
| General and administrative | 1,386 | 1,183 | 1,362 | 1,865 |
| Sales and marketing | 304 | 257 | 290 | 140 |
| Research and development | 323 | 382 | 348 | 298 |
| Gain (loss) on derivative instruments, net, pretax | - | - | - | 160 |
| Total operating expenses | 2,013 | 1,822 | 2,000 | 2,303 |
| Change in fair value of yorkville note | - | -34 | -30 | -262 |
| Loss from operations | -2,235 | -2,063 | -2,224 | -2,387 |
| Change in fair value of pipe notes | - | -1,088 | -133 | -77 |
| Interest expense | 6 | 22 | 31 | 36 |
| Change in fair value of warrants | 20 | 0 | 3 | 6 |
| Change in fair value of crypto assets bitcoin | 55 | -174 | -662 | -124 |
| Realized (gain) loss on sale of crypto assets bitcoin | 54 | 314 | 531 | - |
| Stock warrant expense | - | 0 | - | - |
| Change in fair value of derivative liability | -402 | 110 | 324 | - |
| Gain on troubled debt restructurings | 1,862 | 3,707 | - | - |
| Loss on extinguishment of debt | -41 | - | - | - |
| Other expense (income) | -8 | -12 | - | -4 |
| Total other (income) expense, net | 1,494 | 5,045 | 322 | 329 |
| Net income (loss) | -741 | 2,982 | -1,902 | -2,058 |
| Net income (loss) per share attributable to common shares basic | -0.01 | 0.07 | -0.06 | -0.07 |
| Net income (loss) per share attributable to common shares diluted | -0.01 | 0.07 | -0.06 | -0.07 |
| Weighted average shares of common stock outstanding basic | 52,618,031 | 36,835,945 | 34,103,724 | 27,878,399 |
| Weighted average shares of common stock outstanding diluted | 52,618,031 | 38,405,921 | 34,103,724 | 27,878,399 |
OneMedNet Corp (ONMD)
OneMedNet Corp (ONMD)